Xavier Rabasseda

Summary

Affiliation: Thomson Reuters
Country: UK

Publications

  1. doi Highlights from the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    Xavier Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:49-67. 2010
  2. doi New music to an old melody: The 66th AAAAI meeting in New Orleans
    Xavier Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drug News Perspect 23:211-5. 2010
  3. ncbi A report from the American Academy of Neurology 2014 Annual Meeting (April 26-May 3 - Philadelphia, Pennsylvania, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 50:445-60. 2014
  4. ncbi A report from the 29th Annual Congress of the European Association of Urology (April 11-15 - Stockholm, Sweden)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 50:385-95. 2014
  5. ncbi A report from the 72nd annual meeting of the American Academy of Dermatology (March 21-25 - Denver, Colorado, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 50:321-32. 2014
  6. doi The Liver Meeting 2013: a report from the 64th meeting of the American Association for the Study of the Liver (November 1-5, 2013 - Washington, D.C., USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:809-22. 2013
  7. doi A report from the European Society of Cardiology Congress 2013 (August 31-September 4, 2013 - Amsterdam, the Netherlands)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:575-91. 2013
  8. doi A report from the American College of Rheumatology 2013 Meeting (October 26-30, 2013 - San Diego, California, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:717-37. 2013
  9. doi A report from the 22nd Congress of the European Academy of Dermatology and Venereology (October 2-6, 2013 - Istanbul, Turkey)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:667-77. 2013
  10. doi A report from the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (June 30-July 3, 2013 - Kuala Lumpur, Malaysia)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:509-17. 2013

Detail Information

Publications55

  1. doi Highlights from the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    Xavier Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:49-67. 2010
    ..The meeting contained a number of important new contributions with a direct impact in how patients are and can be treated in the current clinical setting...
  2. doi New music to an old melody: The 66th AAAAI meeting in New Orleans
    Xavier Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drug News Perspect 23:211-5. 2010
    ..Indeed, nights on Bourbon Street had never been so uncrowded as they were during the meeting, suggesting that attendees were perhaps sequestered in their hotel rooms, working with new information obtained at the meeting...
  3. ncbi A report from the American Academy of Neurology 2014 Annual Meeting (April 26-May 3 - Philadelphia, Pennsylvania, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 50:445-60. 2014
    ..But the science was worth staying indoors to witness high-quality research, as summarized in this report. ..
  4. ncbi A report from the 29th Annual Congress of the European Association of Urology (April 11-15 - Stockholm, Sweden)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 50:385-95. 2014
    ....
  5. ncbi A report from the 72nd annual meeting of the American Academy of Dermatology (March 21-25 - Denver, Colorado, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 50:321-32. 2014
    ..This report summarizes the most significant new scientific findings reported during the meeting, which have a direct impact on how diseases of the skin are or will possibly be treated in the foreseen future. ..
  6. doi The Liver Meeting 2013: a report from the 64th meeting of the American Association for the Study of the Liver (November 1-5, 2013 - Washington, D.C., USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:809-22. 2013
    ..This report briefly reviews many of the new scientific findings coming from clinical and preclinical studies aimed at improving the care of patients suffering from hepatic conditions. ..
  7. doi A report from the European Society of Cardiology Congress 2013 (August 31-September 4, 2013 - Amsterdam, the Netherlands)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:575-91. 2013
    ..This report is a sample of the new science discussed during the 5 days of meetings. ..
  8. doi A report from the American College of Rheumatology 2013 Meeting (October 26-30, 2013 - San Diego, California, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:717-37. 2013
    ..The following report summarizes a selection of oral and poster presentations that reflect the state of the art of current rheumatology pharmacotherapy and what is arising as novel investigational therapy. ..
  9. doi A report from the 22nd Congress of the European Academy of Dermatology and Venereology (October 2-6, 2013 - Istanbul, Turkey)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:667-77. 2013
    ..Many other topics of interest were also discussed during the meeting's sessions and electronic poster presentations, as summarized in the report. ..
  10. doi A report from the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (June 30-July 3, 2013 - Kuala Lumpur, Malaysia)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:509-17. 2013
    ..These, and many other important news derived from research into novel approaches to fight HIV infection were discussed during the International AIDS Society (IAS) meeting in Kuala Lumpur, as summarized in the following report. ..
  11. doi A report from the American Society of Hypertension 28th Annual Scientific Meeting and Exposition (May 15-18, 2013 - San Francisco, California, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:463-70. 2013
    ..Research continues, as the morbidity and mortality associated with hypertension is better recognized as a threat in aging populations worldwide. ..
  12. doi A report from the 26th International Conference on Antiviral Research (May 11-15, San Francisco, California, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:411-7. 2013
    ..et al., Abst 104). ..
  13. doi A report from the 28th Annual European Association of Urology Congress (March 3-7, 2013 - Milan, Italy)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:271-82. 2013
    ....
  14. doi 2012 in review - part II: overcoming the obstacles in the pharma/biotech industry
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:117-43. 2013
    ....
  15. doi A report from the American Heart Association Scientific Sessions 2012 (November 3-7 - Los Angeles, California, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 49:69-84. 2013
    ..A summary of the most relevant findings among the over 4,000 abstracts presented during the meeting are reported in the following report...
  16. doi A report from the 42nd Annual Meeting of the International Continence Society (October 15-19 - Beijing, China)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:741-51. 2012
    ..The following report summarizes selected presentations on pharmacotherapy and drug candidates for overactive bladder and other common diseases of the urinary tract...
  17. doi A report from the 37th Annual Meeting of the International Urogynecological Association (September 4-8 - Brisbane, Australia)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:685-91. 2012
    ..The following report summarizes state-of-the-art therapies for common urogynecological diseases as discussed in Brisbane during the beautiful pre-spring days in early September 2012...
  18. doi A report from the endocrine society's 94th annual meeting & expo (June 23-26 - Houston, Texas, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:615-25. 2012
    ..New and investigational treatments for these conditions are summarized in the following report, based on the oral and poster presentations during the meeting...
  19. doi A report from the 72nd Scientific Sessions of the American Diabetes Association (June 8-12, 2012 - Philadelphia, Pennsylvania, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:555-72. 2012
    ..Here, new findings with currently available drugs and drugs in advanced clinical research were reported during the meeting's oral and poster sessions and are summarized in the following report...
  20. doi A report from the American Society of Hypertension's 2012 annual scientific meeting and exposition (May 19-22, 2012 - New York, New York, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:493-502. 2012
    ..The following report aims at summarizing clinical and preclinical findings reported during the meeting that have a direct impact on how hypertension and the cardiovascular risk is, should or could possibly be managed in the future...
  21. doi A report from the 22nd European Congress of Clinical Microbiology and Infectious Diseases (March 31-April 4, 2012 - London, UK)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:425-34. 2012
    ..This report will briefly summarize new findings leading to new and putative new treatment modalities for diseases caused by bacteria, fungi, viruses and parasites...
  22. doi A report from the American Academy of Dermatology 70th Annual Meeting (March 16-20, 2012--San Diego, California, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:367-73. 2012
    ..The following report briefly reviews news reported on therapies for skin diseases, focused mostly on new clinical research and the results of randomized, controlled trials...
  23. doi A report from the American Academy of Allergy, Asthma and Immunology 2012 annual meeting (March 2-6, 2012 - Orlando, Florida, U.S.A.)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:303-10. 2012
    ....
  24. doi A report from the 27th Annual Congress Of The European Association Of Urology (February 24-28, 2012 - Paris, France)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:233-43. 2012
    ..The following report reviews many of these findings presented during the meeting, with a most direct impact on the current and future treatment for urological diseases...
  25. doi A report from the American Heart Association Scientific Sessions 2011 (November 12-16, 2011, Orlando, Florida, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:79-94. 2012
    ..These issues were widely discussed in the context of new findings with improved therapies tested in clinical or preclinical studies during AHA's scientific sessions in Orlando, as summarized in the following report...
  26. doi Report from the 29th World Congress of Endourology and SWL (November 30-December 3, 2011 - Kyoto, Japan)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 48:163-71. 2012
    ....
  27. doi A report from the 47th European Association for the Study of Diabetes annual meeting (September 12-16, 2011 - Lisbon, Portugal)
    X Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:923-34. 2011
    ..New findings with currently available drugs and drugs in research that were reported during this year's EASD meeting in the beautiful city of Lisbon are summarized in the following report...
  28. doi A report from the 46th Annual Meeting of the European Association for the Study of Diabetes (September 20-24, 2010 - Stockholm, Sweden)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:77-95. 2011
    ....
  29. doi A report from the 2011 Alzheimer's Association International Conference (July 16-21 - Paris, France)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:869-78. 2011
    ..Fortunately, research has resulted in therapeutic opportunities that were reviewed during the 2011 Alzheimer's Association International Conference (AAIC) in Paris, and will be briefly reviewed in the following report...
  30. doi A report from the European Society of Cardiology Congress 2011 (August 27-31, 2011 -- Paris, France)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:787-802. 2011
    ..For those who could not attend the meeting, Drugs of Today has wrapped up the major take-home messages from the meeting in the following report...
  31. doi A report from the 60th Annual Scientific Session & Expo and I2 (Innovation and Intervention) Summit of the American College of Cardiology (April 2-5, 2011 - New Orleans, Louisiana, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:381-400. 2011
    ....
  32. ncbi Bioinformatic approaches to the study of Chlamydial diseases
    X Rabasseda
    Medical Department, Life Sciences, Healthcare and Science, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 45:173-87. 2009
    ..Bioinformatics may provide the clues necessary for a true breakthrough in the fight against chlamydial diseases: the development of a vaccine...
  33. doi Marching against blood diseases: a report from the 51st Annual Meeting of the American Society of Hematology (December 5-8, 2009 - New Orleans, Lousiana, USA)
    Xavier Rabasseda
    Medical Department, Thomson Reuters, Provença 388, Barcelona, Spain
    Drugs Today (Barc) 46:195-230. 2010
    ....
  34. doi A report from the 4th biennial conference of the international society of bipolar disorder (March 17-20, 2010 - Sao Paulo, Brazil)
    X Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:433-66. 2010
    ....
  35. doi A report from the 68th annual meeting of the American Academy of Dermatology (March 5-9, 2010 - Miami, Florida, USA)
    X Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:437-48. 2010
    ..A fitting message is: "It's cold, but even if it wasn't, cover your skin... even in Miami"...
  36. doi A report from the 20th European Congress of Clinical Microbiology and Infectious Diseases (April 10-13, 2010 - Vienna, Austria)
    X Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:533-42. 2010
    ....
  37. doi A report from the 106th International Conference of the American Thoracic Society (May 14-19, 2010 - New Orleans, Louisiana, USA)
    X Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:609-29. 2010
    ..et al., A4144). However, many other therapeutic issues of interest competed with all the attractions in New Orleans for the attention of congress attendees, and are briefly summarized in the following report...
  38. doi A report from the 46th Annual Meeting of the American Society of Clinical Oncology (June 4-8, 2010 - Chicago, Illinois, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:699-731. 2010
    ....
  39. doi A report from the 47th Annual Meeting of the American Society of Clinical Oncology (June 3-7, 2011 - Chicago, Illinois, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:693-737. 2011
    ..The following report provides a quick review of major new research into drug and support therapies for cancer as presented at the meeting...
  40. ncbi A report from the 164th American Psychiatric Association (May 14-18, 2011 - Honolulu, Hawai'i, U.S.A.)
    Xavier Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:625-44. 2011
    ..The following report summarizes the main findings from clinical and experimental studies related to new psychiatric pharmacotherapies as reported and discussed during the meeting...
  41. doi A report from the XVIII International AIDS Conference. (July 18-23, 2010-Vienna, Austria)
    Xavier Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:945-57. 2010
    ..All information across the meeting related to therapies for HIV infection are briefly reviewed in the following report, which complements and guides through the extensive information available on the organizing society's website...
  42. doi A report from the 2011 annual meeting of the american academy of Allergy, Asthma and Immunology (March 18-22, 2011 - San Francisco, California, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:313-23. 2011
    ..Most of the new research directly related to therapy for immunological diseases and disorders is summarized in the following report...
  43. ncbi Contentious controversies: a report from the 3rd World Congress on Controversies in Urology (February 25-28, 2010, Athens, Greece)
    Xavier Rabasseda
    Medical Department, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:291-6. 2010
    ..The following is a review of major topics directly related to urological therapy as presented during the meeting...
  44. doi A report from the 69th annual meeting of the American Academy of Dermatology (February 4-8, 2011 - New Orleans, Louisiana, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 47:233-47. 2011
    ..et al., Abst P102)...
  45. doi A report from the 13th International Conference on Alzheimer's Disease and Related Disorders (ICAD) (July 10-15, 2010-Honolulu, Hawaii, USA)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:875-87. 2010
    ....
  46. doi Through the steps of history: a report from the Annual European Congress of Rheumatology (EULAR) (June 16-19, 2010 - Rome, Italy)
    X Rabasseda
    Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:785-811. 2010
    ..EULAR offers a yearly development on therapies for diseases with a clear, direct negative impact on physical functioning of the sufferers, and this report will review most of the therapeutic novelties discussed this year...
  47. ncbi Enhanced hypercholesterolemia therapy: the ezetimibe/simvastatin tablet
    Patrick Cole
    Medical Information Department, Prous Science, Barcelona, Spain
    Drugs Today (Barc) 41:317-27. 2005
    ..These findings indicate that use of the ezetimibe/simvastatin single tablet will allow more patients to meet increasingly stringent LDL cholesterol goals, thereby avoiding negative cardiovascular outcomes...
  48. ncbi Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression
    Xavier Rabasseda
    Medical Information Department, Prous Science, Barcelona, Spain
    Drugs Today (Barc) 40:773-90. 2004
    ..Duloxetine is a safe and well-tolerated new treatment option for depression including anxiety and painful physical symptoms. Furthermore, duloxetine has proven robust efficacy in stress urinary incontinence...
  49. ncbi Quetiapine in bipolar disorder: Increasing evidence of efficacy and tolerability
    Patrick Cole
    Medical Information Department, Prous Science, Provença 388, Barcelona 08025, Spain
    Drugs Today (Barc) 40:837-52. 2004
    ..A phase III trial program in bipolar disorder is presently ongoing and includes five randomized, double-blind, controlled trials already reported and several other studies which are ongoing or planned...
  50. ncbi Dutasteride: a potent dual inhibitor of 5-alpha-reductase for benign prostatic hyperplasia
    Xavier Rabasseda
    Medical Information Department, Prous Science, Barcelona, Spain
    Drugs Today (Barc) 40:649-61. 2004
    ....
  51. ncbi Focus on neurologic diseases: a report from the 59th American Academy of Neurology annual meeting
    Xavier Rabasseda
    Prous Science, Barcelona, Spain
    Timely Top Med Cardiovasc Dis 11:E13. 2007
  52. ncbi [Fingolimod in the treatment of multiple sclerosis. Novelties presented at the annual congress of the American Academy of Neurology (Toronto, April 2010)]
    Xavier Rabasseda
    Prous Science, Thomson Reuters, Barcelona, Spain
    Drugs Today (Barc) 46:1-14. 2010
    ....
  53. ncbi Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndrome
    Patrick Cole
    Medical Information Department, Prous Science, Provença 388, 08025 Barcelona, Spain
    Drugs Today (Barc) 40:1013-30. 2004
    ..Tegaserod has been safely employed in clinical trials where it has demonstrated efficacy in normalizing intestinal function, thereby improving irritable bowel syndrome symptoms...
  54. ncbi The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease
    Patrick Cole
    Medical Information Department, Prous Science, Provença 388, 08025 Barcelona, Spain
    Drugs Today (Barc) 40:281-324. 2004
    ..In addition to the treatment of adult and juvenile rheumatoid arthritis, etanercept has also demonstrated utility in treating ankylosing spondylitis and psoriatic arthritis...
  55. ncbi Olmesartan, an AT1-selective antihypertensive agent
    Kim Chilman-Blair
    Medical Information Department, Prous Science, Barcelona, Spain
    Drugs Today (Barc) 39:745-61. 2003
    ..Thus, olmesartan appears to be a very promising new therapy for the treatment of hypertension...